Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a093994a6b18248faeafb067793b734 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6807 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7df54b1d8447431b6fc27156890aeb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_308fe9b3b1ab2b04334971a8cba116b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf80aa02452094c874247b77cfebe3f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b06b031c8c95476463d61413328276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de810fa590ed74b26bf93a146c8d87ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f70cfa5b50d0962f573d8b3d4528979 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be505c6c7896cf9c0e945185d24de9de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1626fe6b56a4feb669387727c0b1763d |
publicationDate |
2022-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11446387-B2 |
titleOfInvention |
Compositions and methods of treating muscle dystrophy |
abstract |
Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707532-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022409735-A1 |
priorityDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |